# clm_304B07F7B38F

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_operating_income  
value: 2,237,000,000 United States dollar  
valid_from: 2019-03-31  
valid_to: 2019-06-30  
published: 2019-05-08  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_6CBC8FA47C02  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly operating income: 2,237,000,000 United States dollar", as of 2019-03-31 (until 2019-06-30). Claim clm_304B07F7B38F, https://asof.is/claim/clm_304B07F7B38F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209519000014/0000882095-19-000014-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2019, filed 2019-05-08  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209519000014/0000882095-19-000014-index.htm (primary, SEC EDGAR 10-Q Q1 FY2019, published 2019-05-08)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_operating_income | 2,623,000,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_304B07F7B38F](/claim/clm_304B07F7B38F.md) | [clm_F552A8FA3730](/claim/clm_F552A8FA3730.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
